Carregant...
Extremely High Objective Response Rate of Lenvatinib: Its Clinical Relevance and Changing the Treatment Paradigm in Hepatocellular Carcinoma
Guardat en:
| Publicat a: | Liver Cancer |
|---|---|
| Autor principal: | |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
S. Karger AG
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6170913/ https://ncbi.nlm.nih.gov/pubmed/30319981 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000492533 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|